Endometrial Mucinous Adenocarcinoma
Associated Genetic Biomarkers
NCI Definition: A primary, usually low grade adenocarcinoma of the endometrium in which the majority of the malignant epithelial cells contain abundant intracytoplasmic mucin. 
There are 2 clinical trials for endometrial mucinous adenocarcinoma, of which 2 are open and 0 are completed or closed. Of the trials that contain endometrial mucinous adenocarcinoma as an inclusion criterion, 2 are phase 2 (2 open).
ER and PR are the most frequent gene inclusion criteria for endometrial mucinous adenocarcinoma clinical trials .
Abemaciclib, atezolizumab, and bevacizumab are the most common interventions in endometrial mucinous adenocarcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.